CalciMedica, Inc.
CALC
$2.79
$0.010.36%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
8/19/2025
-
MarketBeat
8/23/2025
-
Ticker Report
8/22/2025
-
MarketBeat
8/21/2025
-
GuruFocus
8/20/2025
-
MarketBeat
8/18/2025
-
GuruFocus
8/12/2025
-
GuruFocus
8/12/2025
-
GuruFocus
8/12/2025
-
GuruFocus
8/12/2025
-
The Fly
8/12/2025
-
PR Newswire
8/7/2025
-
Ticker Report
7/19/2025
-
MarketBeat
7/19/2025
-
Ticker Report
7/18/2025
-
GuruFocus
7/11/2025
-
Insider Monkey
7/11/2025
-
Market News Video
7/8/2025
-
GuruFocus
7/8/2025
-
GuruFocus
7/8/2025
-
PR Newswire
6/27/2025
-
Simply Wall St
6/25/2025
-
GuruFocus
6/25/2025
-
The Fly
6/25/2025
-
PR Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, August 12, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 952 5500
Address
505 Coast Boulevard South
La Jolla, CA 92037
La Jolla, CA 92037
Country
Year Founded
--
Business Description
Sector
CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The...
more